REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5 | -100.0% | 41,637 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -44.4% | 41,637 | 0.0% | 0.00% | – |
| Q2 2022 | $36,000 | -65.4% | 41,637 | 0.0% | 0.00% | – |
| Q1 2022 | $104,000 | +52.9% | 41,637 | +57.6% | 0.00% | – |
| Q4 2021 | $68,000 | -45.2% | 26,419 | -2.5% | 0.00% | – |
| Q3 2021 | $124,000 | -33.7% | 27,091 | -0.5% | 0.00% | – |
| Q2 2021 | $187,000 | +3.9% | 27,229 | +10.3% | 0.00% | – |
| Q1 2021 | $180,000 | +7.1% | 24,689 | +18.3% | 0.00% | – |
| Q4 2020 | $168,000 | -21.1% | 20,875 | 0.0% | 0.00% | – |
| Q3 2020 | $213,000 | +59.0% | 20,875 | +4.0% | 0.00% | – |
| Q2 2020 | $134,000 | +76.3% | 20,065 | +19.0% | 0.00% | – |
| Q1 2020 | $76,000 | -62.7% | 16,864 | -50.0% | 0.00% | – |
| Q4 2019 | $204,000 | +72.9% | 33,728 | +100.0% | 0.00% | – |
| Q3 2019 | $118,000 | +8.3% | 16,864 | 0.0% | 0.00% | – |
| Q2 2019 | $109,000 | -0.9% | 16,864 | +27.3% | 0.00% | – |
| Q1 2019 | $110,000 | -24.7% | 13,251 | -50.0% | 0.00% | – |
| Q4 2018 | $146,000 | – | 26,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |